Suppr超能文献

非典型脑膜瘤全切或次全切术后早期或晚期放疗:临床疗效与局部控制情况

Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.

作者信息

Dohm Ammoren, McTyre Emory R, Chan Michael D, Fan Claire, Isom Scott, Bourland J Daniel, Mott Ryan T, Cramer Christina K, Tatter Stephen B, Laxton Adrian W

机构信息

Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, United States.

Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States.

出版信息

J Clin Neurosci. 2017 Dec;46:90-98. doi: 10.1016/j.jocn.2017.08.023. Epub 2017 Sep 13.

Abstract

We report a single institution series of surgery followed by either early adjuvant or late radiotherapy for atypical meningiomas (AM). AM patients, by WHO 2007 definition, underwent subtotal resection (STR) or gross total resection (GTR). Sixty-three of a total 115 patients then received fractionated or stereotactic radiation treatment, early adjuvant radiotherapy (≤4months after surgery) or late radiotherapy (at the time of recurrence). Kaplan Meier method was used for survival analysis with competing risk analysis used to assess local failure. Overall survival (OS) at 1, 2, and 5years for all patients was 87%, 85%, 66%, respectively. Progression free survival (PFS) at 1, 2, and 5years for all patients was 65%, 30%, and 18%, respectively. OS at 1, 2, and 5years was 75%, 72%, 55% for surgery alone, and 97%, 95%, 75% for surgery+radiotherapy (log-rank p-value=0.0026). PFS at 1, 2, and 5years for patients undergoing surgery without early adjuvant radiotherapy was 64%, 49%, and 27% versus 81%, 73%, and 59% for surgery+early adjuvant radiotherapy (log-rank p-value=0.0026). The cumulative incidence of local failure at 1, 2, and 5years for patients undergoing surgery without early External Beam Radiation Therapy (EBRT) was 18.7%, 35.0%, and 52.9%, respectively, versus 4.2%, 13.3%, and 20.0% for surgery and early EBRT (p-value=0.02). Adjuvant radiotherapy improves OS in patients with AM. Early adjuvant radiotherapy improves PFS, likely due to the improvement in local control seen with early adjuvant EBRT.

摘要

我们报告了一个单一机构的系列研究,该研究对非典型脑膜瘤(AM)患者进行手术,术后接受早期辅助放疗或晚期放疗。根据世界卫生组织2007年的定义,AM患者接受了次全切除(STR)或全切除(GTR)。在总共115例患者中,有63例随后接受了分次或立体定向放射治疗,即早期辅助放疗(手术后≤4个月)或晚期放疗(复发时)。采用Kaplan-Meier方法进行生存分析,并使用竞争风险分析来评估局部失败情况。所有患者1年、2年和5年的总生存率(OS)分别为87%、85%、66%。所有患者1年、2年和5年的无进展生存率(PFS)分别为65%、30%和18%。单纯手术患者1年、2年和5年的OS分别为75%、72%、55%,手术+放疗患者为97%、95%、75%(对数秩检验p值=0.0026)。未接受早期辅助放疗的手术患者1年、2年和5年的PFS分别为64%、49%和27%,而手术+早期辅助放疗患者为81%、73%和59%(对数秩检验p值=0.0026)。未接受早期外照射放疗(EBRT)的手术患者1年、2年和5年的局部失败累积发生率分别为18.7%、35.0%和52.9%,而手术联合早期EBRT患者为4.2%、13.3%和20.0%(p值=0.02)。辅助放疗可提高AM患者的OS。早期辅助放疗可提高PFS,这可能是由于早期辅助EBRT能改善局部控制。

相似文献

1
Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
J Clin Neurosci. 2017 Dec;46:90-98. doi: 10.1016/j.jocn.2017.08.023. Epub 2017 Sep 13.
2
Early adjuvant radiotherapy in the treatment of atypical meningioma.
J Clin Neurosci. 2016 Jun;28:87-92. doi: 10.1016/j.jocn.2015.09.021. Epub 2016 Jan 8.
3
Adjuvant radiotherapy for atypical meningiomas.
J Neurosurg. 2017 Jun;126(6):1822-1828. doi: 10.3171/2016.5.JNS152809. Epub 2016 Sep 9.
5
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531.
6
Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Neuro Oncol. 2017 Sep 1;19(9):1263-1270. doi: 10.1093/neuonc/nox007.
7
Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
Neurosurgery. 2014 Oct;75(4):347-54; discussion 354-5; quiz 355. doi: 10.1227/NEU.0000000000000461.
8
Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
World Neurosurg. 2017 Jul;103:655-663. doi: 10.1016/j.wneu.2017.04.095. Epub 2017 Apr 24.
10
Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma.
Neurol Res. 2022 May;44(5):468-474. doi: 10.1080/01616412.2021.2022915. Epub 2021 Dec 30.

引用本文的文献

1
A high content clonogenic survival drug screening identifies maytansine as a potent radiosensitizer for meningiomas.
Front Immunol. 2025 Mar 18;16:1557165. doi: 10.3389/fimmu.2025.1557165. eCollection 2025.
2
Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma.
Adv Radiat Oncol. 2025 Jan 25;10(3):101726. doi: 10.1016/j.adro.2025.101726. eCollection 2025 Mar.
3
Outcomes of adjuvant radiation treatment following subtotal resection of world health organization grade II meningiomas.
J Neurooncol. 2025 Feb;171(3):609-617. doi: 10.1007/s11060-024-04878-x. Epub 2024 Nov 13.
5
Rethinking the effects of adjuvant beam radiation therapy on overall survival in atypical meningioma patients: age considerations.
Front Neurol. 2024 Mar 15;15:1360741. doi: 10.3389/fneur.2024.1360741. eCollection 2024.
6
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Nat Med. 2023 Dec;29(12):3067-3076. doi: 10.1038/s41591-023-02586-z. Epub 2023 Nov 9.
7
Radiotherapy for Meningioma.
Adv Exp Med Biol. 2023;1416:95-106. doi: 10.1007/978-3-031-29750-2_8.
8
Cost-Effectiveness Analysis of Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma.
AJNR Am J Neuroradiol. 2023 Jul;44(7):783-791. doi: 10.3174/ajnr.A7901. Epub 2023 Jun 8.
9
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues.
Neurosurg Rev. 2022 Oct;45(5):3019-3033. doi: 10.1007/s10143-022-01806-3. Epub 2022 Jun 4.
10
Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.
Front Oncol. 2021 Dec 2;11:787962. doi: 10.3389/fonc.2021.787962. eCollection 2021.

本文引用的文献

2
Adjuvant radiotherapy for atypical meningiomas.
J Neurosurg. 2017 Jun;126(6):1822-1828. doi: 10.3171/2016.5.JNS152809. Epub 2016 Sep 9.
3
Recent advances in the management of atypical meningiomas.
Neurochirurgie. 2016 Aug;62(4):213-22. doi: 10.1016/j.neuchi.2016.02.003. Epub 2016 Jun 28.
4
Early adjuvant radiotherapy in the treatment of atypical meningioma.
J Clin Neurosci. 2016 Jun;28:87-92. doi: 10.1016/j.jocn.2015.09.021. Epub 2016 Jan 8.
5
Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
J Clin Neurosci. 2015 Nov;22(11):1742-8. doi: 10.1016/j.jocn.2015.03.054. Epub 2015 Jul 23.
6
Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Neuro Oncol. 2015 Aug;17(8):1166-73. doi: 10.1093/neuonc/nov069. Epub 2015 May 24.
8
Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.
Cancer. 2015 Jul 15;121(14):2400-10. doi: 10.1002/cncr.29379. Epub 2015 Apr 14.
9
The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
World Neurosurg. 2015 Jun;83(6):987-95. doi: 10.1016/j.wneu.2015.02.021. Epub 2015 Mar 11.
10
An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Neurosurg Focus. 2015 Mar;38(3):E3. doi: 10.3171/2015.1.FOCUS14757.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验